Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.

The investment will expand RNA T&T's operations and allow partners of both companies to leverage combined expertise in RNA-LNP therapeutics.

Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...

An individual’s genome is identifiable. But datasets of RNA sequences from single cells are like a blurry photocopy of the genome. The sequence numbers are small, the data are noisy, and the sequences ...

Our results demonstrate that differential connectivity analysis reveals significant transcriptional alterations that are not ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled "A ...

UC Vice President for Research Patrick Limbach is a key figure in the National Academies’ massive undertaking to sequence RNA in the next 15 years. A chemist who leads the University of Cincinnati’s ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, No. 4 (January 25, 2022), pp. 1-11 (11 pages) RNA is a ubiquitous biomolecule that can serve as both catalyst ...